Navigation Links
MedCath Corporation Reports Third Quarter Earnings
Date:8/5/2009

---- Statement of Operations Data: Net revenue $150,904 $154,273 (2.2)% $462,874 $455,168 1.7% Adjusted EBITDA (1) $11,290 $22,747 (50.4)% $49,261 $66,568 (26.0)% Income from operations $2,243 $13,178 (83.0)% $21,868 $37,125 (41.1)% Income from continuing operations $586 $4,902 (88.0)% $4,388 $12,678 (65.4)% Earnings per share from continuing operations, basic $0.03 $0.25 (88.0)% $0.22 $0.62 (64.5)% Earnings per share from continuing operations, diluted $0.03 $0.25 (88.0)% $0.22 $0.62 (64.5)% (1) See Supplemental Financial Disclosure--Reconciliation of GAAP Financial Measures to Non-GAAP Financial Measures. Three Months Ended Nine Months Ended June 30, June 30, -------- -------- 2009 2008 % Change 2009 2008 % Change ---- ---- -------- ---- ---- -------- Selected Operating Data (a): Number of hospitals 7 7 7 7 Licensed beds ( c ) 588 449 588 449 Staffed and available beds ( d ) 542 449 542 449 Admissions ( e ) 6,352 7,384 (14.0)% 20,152 22,380 (10.0)% Adjusted admissions ( f ) 10,284 10,341 (0.6)% 30,714 30,979 (0.9)% Patient days ( g ) 25,482 27,132 (6.1)% 78,681 81,853 (3.9)% Adjusted patient days ( h ) 41,174 38,105 8.1% 120,106 113,790 5.6% Average length of stay (days) ( i ) 4.01
'/>"/>
SOURCE MedCath Corporation
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related medicine news :

1. MedCath Corporation Reports Fourth Quarter Earnings and Outlook for Fiscal 2008
2. MedCath Corporation to Present at the BMO Capital Markets 2007 Focus on Healthcare Conference
3. MedCath Corporation to Present at the 26th Annual JPMorgan Healthcare Conference
4. MedCath Corporation to Hold Conference Call on First Quarter Results
5. MedCath Corporation Reports First Quarter Earnings
6. MedCath Plans 60-bed Expansion at TexSAn Heart Hospital
7. MedCath Announces Venture With Two New Jersey Hospitals
8. MedCath Corporation to Present at the Raymond James 29th Annual Institutional Investors Conference
9. MedCath Corporation to Present at the Citi 2008 Small and Mid-Cap Conference
10. MedCath Enters Definitive Agreement to Sell Dayton Heart Hospital to Good Samaritan Hospital-Dayton
11. MedCath Announces Acquisition of Ownership in Arizona Cath Lab

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...andPressJoinEfforttoEducate ,, MEMPHIS,Tenn.,N...lBipolarFoundationandtheMedicAlertFoundationreceiv...m,whichisnowbeingwidelyacceptedasapreventivehealth...olarFoundationreceivedaproclamationofendorsementvi...isianaMitchLandrieu.TheNationalBipolarFoundationst...
(Date:11/25/2009)...simple question has been the focus of intense rese...lates High Blood Pressure in Mice & Men, Does str... has been the focus of intense research for many y...ablished a link between a novel gene, phosducin, a...s well as humans. The studies were directed by sci...
(Date:11/25/2009)...overlook needed care, study finds , , WE...pression can worsen her child,s asthma, U.S. resea...62 black mothers and their children found that chi...ad more frequent asthma symptoms, while children o...frequent asthma symptoms. , The Johns Hopkins C...
(Date:11/25/2009)...swire/--TheAmericanAssociationforHomecareendorsest...hisdesignedtosubstantiallyimprovetoolsandresources...ucedbySen.GeorgeLeMieux(R-Fla.). ,, TheLeMieuxb...forHomecareoutlinedinits13-pointanti-fraudactionpl....Thoseprovisionsincludecallingforreal-timeauditsan...
(Date:11/25/2009)...r in children with autism and related conditions c...medication combined with a structured training pro...earchers and their colleagues. , Published in t...ican Academy of Child and Adolescent Psychiatry , ...of Mental Health (NIMH) Research Units on Pediatri...
Breaking Medicine News(10 mins):Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 2Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 3Health News:New stress-related gene modulates high blood pressure in mice and men 2Health News:Mom's Depression May Worsen Child's Asthma 2Health News:American Association for Homecare Endorses New U.S. Senate Bill, the 'Prevent Health Care Fraud Act of 2009' 2Health News:Parent training key to improved treatment of behavior problems in children with autism 2
...pot on Thursday United States fell short of its 20...Listeria by 50 percent.// The statistics relea...ion reveal that the rate of Listeria food poisoni...steria has started to climb because USDA hasn't es...
...pared by health officials in Tripura has brought t...he government// hospital that has claimed the live.... According to the report, submitted to the ...ia, low birth weight, septicemia, malaria, gastro ...
...ealth, John Hatzistergos, has confirmed that a new... a priority basis.// Stating that he has di...tart the detailed planning process for a new hospi...spital that is needed, and where it should be loca...
...tate of Volgograd, in Russia, has reported the dea...o reports from the state veterinary authorities.//...ly 11 regions in Southern Russia have reported Bir...25 hens that died in Volgograd, have tested positi...
...itled ‘Challenging Intellectual Property’ will be ...w York.// The Symposium will look into the a...ciated epitomes of knowledge production in economi... research and development, and enable affordable d...
...hundreds of patients who contracted Hepatitis C in...ing of their condition.// This is same as delayed ...ottish Blood Transfusion Service ,Frank McGuire, a... some had infected their partners. During ...
Other Medicine News:Health News:Government Hospital’s Poor Functioning Claims Lives Of 138 Infant 2Health News:Construction Of A New Hospital In The Bega Area Confirmed 2
(Date:11/25/2009)...Nov.25/PRNewswire-FirstCall/--Abaxis,Inc.(Nasdaq: ...f-carebloodanalysissystems,announcedtodaythatClint...entatthe21stAnnualPiperJaffrayHealthCareConference...cewillbeheldattheNewYorkPalaceHotelinNewYorkCity. ...resandmarketsportablebloodanalysissystemsforuseina...
(Date:11/25/2009)...ov.25/PRNewswire/--CempraPharmaceuticalsInc.todaya...executiveofficer,willpresentatthePiperJaffray21stA...009,atTheNewYorkPalaceHotelinNewYorkCity.Dr.Fernan...tibioticclinicalprogramsforthetreatmentofdrug-resi...rmaceuticals ,, Foundedin2006,CempraPharmaceut...
(Date:11/25/2009)...ndSYDNEY,Nov.25/PRNewswire-FirstCall/--HeartWareIn...novatorandprovideroflessinvasive,miniaturizedcircu...ntofadvancedheartfailure,todayannouncedthatitissch...iperJaffrayHealthCareConferenceat8:00amESTonWednes...wYorkPalaceHotel,December1-2. ,, Alivewebcastof...
Breaking Medicine Technology:Evolution of a contraceptive for sea lamprey 8994 1Evolution of a contraceptive for sea lamprey 8994 2Siemens Healthcare Testifies on Healthcare Reform and Building a Healthier America 49989 1Siemens Healthcare Testifies on Healthcare Reform and Building a Healthier America 49989 2Siemens Healthcare Testifies on Healthcare Reform and Building a Healthier America 49989 3Statement of Dr Elena Rios MD MSPH President and CEO National Hispanic Medical Association 49986 1
...: The Takeda Oncology,Company today reported the P...pany-sponsored Phase I/II study of VELCADE, dexame... in patients with previously untreated multiple,my... data showed that the,combination of four drugs wa...eived no prior therapies and response rates were e...
...aiichi Sankyo,Company, Limited (TSE: 4568), announ...III trial for DU-176b, an investigational oral Fac...tion. DU-176b is being developed,solely by Daiich...ctive Anticoagulation with Factor Xa Next,Generati...l compare DU-176b,with warfarin in preventing stro...
Other Medicine Technology:Novel VELCADE(R) (Bortezomib) for Injection Based Four-Drug Combination Was Well Tolerated In Previously Untreated Multiple Myeloma Patients 2Novel VELCADE(R) (Bortezomib) for Injection Based Four-Drug Combination Was Well Tolerated In Previously Untreated Multiple Myeloma Patients 3Novel VELCADE(R) (Bortezomib) for Injection Based Four-Drug Combination Was Well Tolerated In Previously Untreated Multiple Myeloma Patients 4Novel VELCADE(R) (Bortezomib) for Injection Based Four-Drug Combination Was Well Tolerated In Previously Untreated Multiple Myeloma Patients 5Novel VELCADE(R) (Bortezomib) for Injection Based Four-Drug Combination Was Well Tolerated In Previously Untreated Multiple Myeloma Patients 6Daiichi Sankyo Initiates Phase III Trial of Its Investigational Factor Xa Inhibitor, DU-176b, in Patients With Atrial Fibrillation 2Daiichi Sankyo Initiates Phase III Trial of Its Investigational Factor Xa Inhibitor, DU-176b, in Patients With Atrial Fibrillation 3Daiichi Sankyo Initiates Phase III Trial of Its Investigational Factor Xa Inhibitor, DU-176b, in Patients With Atrial Fibrillation 4